NORBIT ASA
10.2.2021 16:04:02 CET | Globenewswire | Press release
Per Jørgen Weisethaunet, CEO and primary insider of NORBIT ASA has on 10 February 2020 purchased 15,000 shares in NORBIT at an average price of NOK 21.16 per share.
Following the transaction, Weisethaunet owns 6,940,695 shares through the company Petors AS. In addition, related parties of Weisethaunet own 7,893 shares, so that the total number of shares controlled by Weisethaunet and related parties amounts to 6,948,588 shares, representing 12.24 per cent of the outstanding shares in NORBIT.
For further queries, please contact:
Per Kristian Reppe, CFO, +47 900 33 203
About NORBIT ASA
NORBIT is a global provider of tailored technology to carefully selected niches. The company's business is structured to address its key markets; Oceans is offering tailored technology solutions to global maritime markets, Intelligent Traffic Systems (ITS) is offering connectivity solutions for vehicle identification and tracking, and Product Innovation and Realization (PIR) is offering R&D services and contract manufacturing to key customers.
NORBIT is headquartered in Trondheim, Norway. The company has manufacturing facilities in Selbu and Røros, Norway, and 14 offices and subsidiaries around the world.
For more information: www.norbit.com
This information is subject of the disclosure requirements acc. To section 5-12 of the Securities Trading Act.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Tecan Group AG16.3.2026 06:00:00 CET | Press release
Tecan presents 2025 results and provides details on program to reignite profitable growth
King Faisal Specialist Hospital & Research Centre13.3.2026 22:15:53 CET | Press release
KFSH Leads Globally in Paired Kidney Transplants Performed at a Single Center in 2025
SCOR13.3.2026 18:59:39 CET | Press release
SCOR SE announces the availability of its 2025 Universal Registration Document
Novartis Pharma AG13.3.2026 18:35:19 CET | Press release
Novartis Cosentyx® receives FDA approval for pediatric patients aged 12+ with moderate to severe hidradenitis suppurativa
Luotea Oyj13.3.2026 18:30:00 CET | Press release
The Board of Directors of Luotea Oyj decided on updates to the company's share-based incentive plan for 2023-2027 and on the launch of a new share-based incentive plan for the years 2026-2030
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
